Alibaba Takes on Nvidia
Alibaba’s push to dismantle Nvidia’s software lock-in through open-source tools coincides with its largest-ever pre-IPO bet on domestic memory chips, even as the company’s shares sit 19.7 percent lower for the year. These moves signal a deliberate…
Apple AI Clears China Hurdle
Apple Intelligence has cleared a critical regulatory hurdle in China after more than a year of delays, enabling the iPhone maker to deploy its generative AI suite to users in the world’s largest smartphone market through partnerships with Alibaba’s Qwen…
Alibaba’s AI Push Faces US Scrutiny
Alibaba’s push into embodied artificial intelligence is colliding with renewed U.S. political scrutiny and shifting investor sentiment, revealing how Chinese technology firms must simultaneously advance technical roadmaps, manage regulatory exposure, and…
Alibaba Fined $600M
Alibaba’s $600 million settlement with the Justice Department exposes a stark gap between the evidence investigators assembled and the penalties ultimately imposed. Prosecutors had documented eight years of unchecked sales of dangerous drugs, chemicals,…
Alibaba Shares Soar
Alibaba’s shares surged more than 11 percent on a single trading session, the largest one-day gain in nearly a year, as investors weighed fresh analyst optimism against a temporary reprieve from a U.S. military-company designation and tightening…
Alibaba Wins Reprieve
Introduction to Alibaba’s Recent Developments Alibaba Group Holding has secured a significant reprieve in its dispute with the Pentagon, as a judge in the Northern District of California ordered the Department of Defence not to enforce a lobbying…
Alibaba Bans Claude Code
Alibaba’s decision to prohibit its workforce from using Anthropic’s Claude Code marks a sharp escalation in the already tense relationship between leading U.S. and Chinese artificial intelligence developers. The internal directive, effective July 10,…
Alibaba Pays $600M Settlement
Introduction to Alibaba’s Settlement Alibaba, the Chinese e-commerce giant, has agreed to pay $600 million to settle allegations with the U.S. government over the sale and importation of illegal pharmaceuticals, controlled substances, and…
Alibaba Pays $600M
Alibaba Group’s agreement to pay $600 million to resolve a Department of Justice investigation into the facilitation of illegal pharmaceutical and chemical imports underscores the mounting compliance costs facing Chinese technology platforms that serve…
Alibaba Accused of AI Scraping
The e-commerce giant Alibaba has found itself at the center of several significant developments, ranging from accusations of using fake accounts to scrape AI models to terminations of lobbying contracts with major firms in Washington. One of the most…